K2M Strengthens Biologics Portfolio With Launch Of VENADO Bone Graft Systems
VENADO represents an entirely new product family in K2M's growing biologics portfolio, already featuring VIKOS® Allograft Systems and VESUVIUSTM Osteobiologic Systems.
Leesburg, VA (I-Newswire) March 28, 2013 - - K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced a major expansion of the company's U.S. biologics offering with the launch of the VENADO® Foam Strips and VENADO Granules Bone Graft Systems.
VENADO represents an entirely new product family in K2M's growing biologics portfolio, already featuring VIKOS® Allograft Systems and VESUVIUSTM Osteobiologic Systems. The systems are available in a variety of configurations and sizes specifically designed to enhance bone regeneration and act as an osteogenic stimulus after spine surgery. VENADO Foam Strips are purified fibrillar collagen and biphasic granules. The Foam Strips hydrate quickly in blood or saline, and become very flexible and moldable, yet are less likely to dissociate or break apart. When bone cells migrate into the graft composite, the implant functions as a scaffold for osteogenic components. VENADO Granules are a biphasic combination of hydroxyapatite and beta-tricalcium phosphate with excellent resorption characteristics.
According to Dr. Faheem Sandhu, neurosurgeon and Associate Professor at Georgetown University Hospital, "VENADO provides for synthetic bone graft alternatives for hospitals and surgeons interested in a non-allograft solution to the management of complex spinal surgical issues, and these unique products complement and enhance K2M's already comprehensive and innovative spine portfolio."
"We are excited to bring to market the VENADO Bone Graft Systems and to expand on our company's presence in the rapidly growing biologics sector," stated Eric Major, K2M's President and CEO. "The launch of VENADO enables us to meet a significant demand for the high quality products surgeons have come to expect from K2M."
# # #
K2M, Inc. is the largest privately held spinal device company in the world focused on the research, development, and commercialization of innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures. The company is recognized as a global leader in providing unique technologies for the treatment of deformity, degenerative, trauma, and tumor spinal patients. K2M's product development pipeline includes: spinal stabilization systems, minimally invasive systems, biologics, and other advancing technologies, such as motion preservation, annular repair, and nucleus replacement. Additional information is available online at www.K2M.com.
Find K2M on Facebook: https://www.facebook.com/K2MInc
Follow K2M on Twitter: http://twitter.com/K2MInc
Watch K2M on YouTube: http://www.youtube.com/user/K2MInc
Zeno Group on behalf of K2M, Inc.
Marcie Kohenak, 202-965-7811
About Zeno Group, on behalf of K2M, Inc.
Zeno Group, on behalf of K2M, Inc.
751 Miller Drive SE
Phone : 2029657811
Published On:March 28, 2013
Print Release:Print Release
If you have questions regarding information in this press release contact the company listed above. I-Newswire.com is a press release service and not the author of this press release.The information that is on or available through this site is for informational purposes only and speaks only as of the particular date or dates of that information. As some companies and PR Agencies submit their press releases once per week,month or quarter, make sure to check the official company website for accurate release dates as our site displays the I-Newswire.com press release distribution date only.We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for or omissions in that information or for actions taken in reliance on that information.
March Is National Save Your Vision Month
Teenager With Cystic Fibrosis To Bicycle Around Colorado For Charity
U.S. Dentists Turn to Reliable Arts Dental Lab For High-Quality, Affordable Dental Products
IMWell Health Announces First Bank Corp Signing On With Fort Smith Multi-Employer Health Clinic
Cochran Firm, D.C. Investigating AndroGel, Axiron And Other Potential Testosterone Replacement Therapy Lawsuit Cases